Coeptis Therapeutics Inc.

NASDAQ: COEP · Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT

Coeptis Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
4.27M 532.88K 1.14M 1.56M 1.03M 1.47M 1.41M 3.24M 2.11M 3.79M 7.37M 2.38M 2.34M 2.18M 584.63K 644.48K 766.69K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
6.94M 5.69M 5.69M 7.55M 5.5M 3.5M 2.5M n/a n/a n/a 33.27M 32.99M 75.77M 75.76M 75.76M 75.75M 75.75M
Other Long-Term Assets
1.3M 1.56M 1.82M 63.33K -3.09M 158.33K 205.83K 253.33K 300.83K 3.9M -29.46M -28.93M -71.46M -71.2M -28.35K -38.54K -48.5K
Receivables
n/a n/a n/a 191.08K 108.58K 38.98K 833.00 n/a n/a 8.07K 8.07K n/a n/a n/a 26.3K 21.79K 21.79K
Inventory
n/a n/a n/a n/a n/a n/a -2.5M 350K n/a n/a -17.14K n/a n/a n/a -26.3K -21.79K -21.79K
Other Current Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 18.67K 46.79K 77.61K
Total Current Assets
4.65M 1.05M 1.36M 1.99M 6.88M 1.75M 4.12M 3.8M 2.28M 3.94M 7.38M 2.38M 2.34M 2.18M 603.3K 691.27K 844.3K
Property-Plant & Equipment
60.1K 59.78K 80.23K 89.99K 99.54K 108.88K 40.29K 50.91K 61.3K 71.46K 81.43K 91.18K 100.72K 31.85K 28.35K 38.54K 48.5K
Goodwill & Intangibles
496.72K 541.88K n/a 2.05M n/a n/a 2.8M 3.05M 3.3M n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
8.8M 7.86M 7.59M 2.21M 2.51M 2.82M 3.05M 3.36M 3.67M 3.97M 3.89M 4.15M 4.4M 4.59M 75.76M 75.75M 75.75M
Total Assets
13.45M 8.91M 8.96M 4.2M 9.39M 4.57M 7.17M 7.16M 5.94M 7.92M 11.26M 6.52M 6.75M 6.77M 76.36M 76.45M 76.6M
Account Payables
1.12M 1.27M 1.13M 1.28M 1.37M 1.42M 482K 395.23K 242.45K 99.02K 327.87K 268.46K 244.79K 134.09K 1.28M 2.75M 1.82M
Deferred Revenue
1.19M n/a n/a n/a n/a n/a -10.76K n/a n/a n/a n/a n/a n/a -14.72K -5.28M 1M 1M
Short-Term Debt
1.84M 1.19M 1.55M 1.55M 2.19M 975K 825K 1.85M 1.5M 1.5M 3.62M 3.66M 2.17M 2.42M 4M 749.6K 1.76M
Other Current Liabilities
870.49K 1.28M n/a n/a n/a n/a n/a 529.18K n/a 350K n/a n/a n/a n/a 46.47K -4.46M 1.09M
Total Current Liabilities
5.65M 4.51M 3.44M 3.63M 4.3M 2.99M 1.62M 2.51M 1.98M 1.82M 4.31M 4.26M 2.71M 2.76M 46.47K 34.44K 31.82K
Long-Term Debt
150K 150K 150K 150K 150K 150K 150K 150K 150K 150K 150K 150K 1.65M 1.65M n/a n/a n/a
Other Long-Term Liabilities
169.13K 359.25K 322.13K 671.62K 522.37K 557.25K 378.38K 1.99M 2.51M 1.13M n/a n/a n/a n/a 6.11M 10.39M 8.74M
Total Long-Term Liabilities
338K 528.13K 533.3K 882.8K 733.55K 768.43K 543.1K 2.15M 2.68M 1.29M 206.34K 206.34K 1.71M 1.65M 6.11M 10.39M 8.74M
Total Liabilities
5.99M 5.04M 3.97M 4.51M 5.03M 3.76M 2.16M 4.67M 4.66M 3.11M 4.52M 4.46M 4.41M 4.41M 6.16M 10.42M 8.77M
Total Debt
2.04M 1.4M 1.77M 1.78M 2.43M 1.22M 1M 2.04M 1.7M 1.71M 3.83M 3.89M 3.9M 4.08M 4M 749.6K 1.76M
Common Stock
337.00 212.00 4K 3.97K 3.64K 3.53K 3.3K 2.44K 2.09K 1.96K 4.2K 3.78K 3.72K 3.55K 75.78M 71.04M 71.04M
Retained Earnings
-101.65M -98.23M -95.22M -93.39M -90.36M -87.36M -82.98M -76.72M -73.61M -65.74M -62.18M -56.53M -46.73M -27.55M -5.58M -5.02M -3.22M
Comprehensive Income
n/a n/a n/a -2 n/a n/a n/a n/a 720K n/a n/a n/a n/a n/a n/a n/a -71.04M
Shareholders Equity
6.48M 3.19M 4.82M 7.11M 4.36M 4.31M 5.01M 2.49M 1.29M 4.8M 6.74M 2.06M 2.34M 2.35M 70.2M 66.02M 67.83M
Total Investments
6.94M 5.69M 5.69M 7.55M 5.5M 3.5M 2.5M n/a n/a n/a 33.27M 32.99M 75.77M 75.76M 75.76M 75.75M 75.75M